208
STUDY VISITS
200+
PATIENTS
22
SITES
71
MDs
16
STATES
Participating Sites
CorEvitas has clinical sites across the U.S. and we are always interested in expanding the registry for qualified sites.
Outcome measures in the CorEvitas NMOSD Registry
Among the variables we collect, some of the key outcome measures to inform your research include:
Disease Characteristics
- Primary Diagnosis
- Year of onset and diagnosis of NMOSD
- Details of neurological episodes (initial and subsequent relapses)
- 2015 IPND international consensus diagnostic criteria characteristics
- Serology Status (AQP4, MOG)
- EDSS (expanded disability status scale) Step Score
- Montreal Cognitive Assessment (MoCA)
- History of Infections
- Comorbidity and Medical History
Patient Reported Outcomes
- Modified Fatigue Impact Scale (MFIS)
- PainDETECT Questionnaire (PD-Q)
- EuroQol Visual Analogue Scale (EQ-VAS)
- 5-level EQ-5D version (EQ-5D-5L)
- Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2)
- Pain Severity Numeric Rating Scale
- Patient Health Questionnaire-2 (PHQ-2)
- Visual Function Questionnaire - Utility Index (VFQ-UI)
Our Partners
In Partnership with the Guthy Jackson Charitable Foundation
Our Publications